Literature DB >> 2547540

The influence of intra-articular hyaluronic acid on PGE2 and cAMP of synovial fluid.

L Punzi1, F Schiavon, F Cavasin, R Ramonda, P F Gambari, S Todesco.   

Abstract

Prostaglandin (PG)E2, cyclic adenosine monophosphate (cAMP), white blood cells (WBC), total protein (TP), total complement activity (CH50) and beta-2-microglobulin (beta-2-m) were measured at baseline and after eight days in the synovial fluid (SF) of 16 patients affected with knee-joint effusion due to various arthropathies. The volume of SF was also calculated. Eight patients--4 with rheumatoid arthritis (RA), 2 with recurrent monoarthritis (RM) and 2 with osteoarthritis (OA) were randomly allocated to the treatment with intra-articular injection of Hyalgan (HA, Na-hyaluronate, 20 mg/2 ml), while eight patients having similar arthropathies--4 RA, 2 RM and 2 OA--were not treated (control group). In the patients treated with HA a significant reduction of SF volume (from 28.5 +/- 5.1 ml to 20.5 +/- 4.0 ml; p less than 0.02) and PGE2 (from 96.1 +/- 22.7 pg/ml to 66.2 +/- 14.5 pg/ml; p less than 0.05) was found, whereas cAMP concentration was significantly increased (from 4.5 +/- 0.7 pmol/ml to 7.2 +/- 1.2 pmol/ml; p less than 0.05). No significant variations were observed in the control group. Moreover, no differences in WBC count, TP and beta-2-m and CH50 were found in either group. These data could suggest an anti-inflammatory effect of HA that appears to be mediated by PG-inhibition as well as cAMP stimulation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2547540

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  15 in total

Review 1.  A pathological role for damaged hyaluronan in synovitis.

Authors:  E B Henderson; M Grootveld; A Farrell; E C Smith; P W Thompson; D R Blake
Journal:  Ann Rheum Dis       Date:  1991-03       Impact factor: 19.103

2.  Intra-articular hyaluronan treatment for osteoarthritis.

Authors:  E George
Journal:  Ann Rheum Dis       Date:  1998-11       Impact factor: 19.103

Review 3.  [Injection treatment with hyaluronic acid].

Authors:  J Jerosch
Journal:  Z Rheumatol       Date:  2015-11       Impact factor: 1.372

Review 4.  Hyaluronic acid (Supartz®): a review of its use in osteoarthritis of the knee.

Authors:  Monique P Curran
Journal:  Drugs Aging       Date:  2010-11-01       Impact factor: 3.923

5.  In vitro effects of hyaluronan on prostaglandin E2 induction by interleukin-1 in rabbit articular chondrocytes.

Authors:  M Akatsuka; Y Yamamoto; K Tobetto; T Yasui; T Ando
Journal:  Agents Actions       Date:  1993-01

6.  The effect of hyaluronan on interleukin-1 alpha-induced prostaglandin E2 production in human osteoarthritic synovial cells.

Authors:  T Yasui; M Akatsuka; K Tobetto; M Hayaishi; T Ando
Journal:  Agents Actions       Date:  1992-09

7.  Does hyaluronan affect inflammatory cytokines in knee osteoarthritis?

Authors:  Melek Sezgin; Alev Cevikol Demirel; Cevriye Karaca; Ozgür Ortancil; Gül Bahar Ulkar; A Kanik; Aytül Cakçi
Journal:  Rheumatol Int       Date:  2004-03-04       Impact factor: 2.631

Review 8.  Hyaluronic acid. A review of its pharmacology and use as a surgical aid in ophthalmology, and its therapeutic potential in joint disease and wound healing.

Authors:  K L Goa; P Benfield
Journal:  Drugs       Date:  1994-03       Impact factor: 9.546

9.  Managing joint pain in osteoarthritis: safety and efficacy of hylan G-F 20.

Authors:  Augustine H Conduah; Champ L Baker; Champ L Baker
Journal:  J Pain Res       Date:  2009-07-06       Impact factor: 3.133

10.  Oral administration of polymer hyaluronic acid alleviates symptoms of knee osteoarthritis: a double-blind, placebo-controlled study over a 12-month period.

Authors:  Toshiyuki Tashiro; Satoshi Seino; Toshihide Sato; Ryosuke Matsuoka; Yasunobu Masuda; Naoshi Fukui
Journal:  ScientificWorldJournal       Date:  2012-11-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.